Stay updated on SAR442720 Combo Study in Advanced Malignancies Clinical Trial

Sign up to get notified when there's something new on the SAR442720 Combo Study in Advanced Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SAR442720 Combo Study in Advanced Malignancies Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:40:02.000Z thumbnail image
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    8 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a shift in the expected duration of study intervention for participants with advanced malignancies. This change may impact the estimated study duration per participant across different study parts involving combinations of SAR442720 with other agents like pembrolizumab and adagrasib.
    Difference
    0.1%
    Check dated 2024-06-06T14:28:08.000Z thumbnail image
  7. Check
    22 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria,' providing examples such as general health condition or prior treatments. Additionally, detailed eligibility criteria for participants, including age, diagnosis, and specific molecular aberrations, have been added.
    Difference
    18%
    Check dated 2024-05-22T20:56:55.000Z thumbnail image
  8. Check
    42 days ago
    Change Detected
    Summary
    The value (Estimated) has recently changed to . This change likely indicates an update or revision in the estimated information related to the medical and healthcare-related publications and documentation on the webpage.
    Difference
    0.0%
    Check dated 2024-05-03T08:08:52.000Z thumbnail image
  9. Check
    43 days ago
    Change Detected
    Summary
    The value 'Active, not recruiting' with EudraCT Number 2020-000436-22 has recently changed to 'Terminated Sponsor's decision not related to any safety concern'. This change indicates that the study has been terminated by the sponsor for reasons unrelated to safety concerns.
    Difference
    2%
    Check dated 2024-05-02T03:32:30.000Z thumbnail image
  10. Check
    44 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:32:57.000Z thumbnail image

Stay in the know with updates to SAR442720 Combo Study in Advanced Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SAR442720 Combo Study in Advanced Malignancies Clinical Trial page.